We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Consumer Orgs Ask 1st Circ. To Ax Momenta Antitrust Shield

Law360, Fort Wayne (January 11, 2017, 3:59 PM EST) -- Public interest groups urged the First Circuit on Tuesday to overturn a lower court's ruling that the Noerr-Pennington doctrine protects drugmaker Momenta from claims that it plotted with Sandoz to keep rival Amphastar from selling a generic version of the anticoagulant Lovenox, saying the court interpreted the doctrine too broadly.

The district court inappropriately expanded the application of Noerr-Pennington when it held in July that Momenta Pharmaceuticals Inc. was immune from the antitrust action by Amphastar Pharmaceuticals Inc., the amicus brief by Consumer Action, the National...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.